- Home
- ORGO
as 01-17-2025 4:00pm EST
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced wound care, surgical and sports medicine markets. Its product category includes Advanced Wound Care and Surgical and Sports Medicine. It has single operating segment which has regenerative medicine. The company generates maximum revenue from Advanced Wound Care products. Some of its products include PuraPly Antimicrobial, Affinity, NuShield, Apligraf, Dermagraft and others.
| Founded: | 1985 | Country: | United States |
| Employees: | N/A | City: | CANTON |
| Market Cap: | 418.7M | IPO Year: | N/A |
| Target Price: | $5.00 | AVG Volume (30 days): | 607.1K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.06 | EPS Growth: | N/A |
| 52 Week Low/High: | $2.17 - $4.57 | Next Earning Date: | 02-27-2025 |
| Revenue: | $455,038,000 | Revenue Growth: | 1.34% |
| Revenue Growth (this year): | 9.65% | Revenue Growth (next year): | 1.57% |
Stock Insider Trading Activity of Organogenesis Holdings Inc. (ORGO)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Gillheeney Gary S. | ORGO | President and CEO | Dec 13 '24 | Sell | $3.43 | 61,200 | $206,358.05 | 3,044,779 | |
| Gillheeney Gary S. | ORGO | President and CEO | Dec 10 '24 | Sell | $3.61 | 259,332 | $940,066.17 | 3,044,779 | |
| Gillheeney Gary S. | ORGO | President and CEO | Dec 5 '24 | Sell | $3.59 | 59,468 | $211,721.44 | 3,044,779 |
Latest Organogenesis Holdings Inc. News
ORGO Breaking Stock News: Dive into ORGO Ticker-Specific Updates for Smart Investing
Simply Wall St.
3 days ago
Organogenesis Holdings Leads These 3 US Penny Stocks
Simply Wall St.
a month ago
US Penny Stocks To Consider In December 2024
MT Newswires
2 months ago
Organogenesis Plans to Boost Manufacturing Capacity
GlobeNewswire
2 months ago
Organogenesis Expands Manufacturing Capacity to Support Future Growth
GlobeNewswire
2 months ago
Organogenesis Commends Final LCDs
GuruFocus.com
2 months ago
Organogenesis Holdings Inc (ORGO) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid ...
Motley Fool
2 months ago
Organogenesis (ORGO) Q3 2024 Earnings Call Transcript
Zacks
2 months ago
Organogenesis (ORGO) Tops Q3 Earnings and Revenue Estimates
Compare ORGO vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ORGO Organogenesis Holdings Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.